一、主要财务数据 浙江医药股份有限公司2025 年第三季度报告 证券代码：600216 证券简称：浙江医药 浙江医药股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 | 年初至报告期末 | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 2,372,423,164.56 | -12.37 | 6,695,297, ...

Financial Performance - The company's revenue for Q3 2025 reached ¥100,050,479.53, representing a 179.96% increase year-over-year[5] - The net profit attributable to shareholders was -¥49,548,386.98, a decrease of 13.28% compared to the same period last year[5] - The basic and diluted earnings per share were both -¥0.47, reflecting a 14.55% improvement year-over-year[5] - The company's operating revenue reached ¥419,615,015.45, an increase of 72.30% compared to the previous period, primarily due to growth in AI 3D digital twin products and integrated digital services[9] - The net loss for the current period was ¥97,789,957.12, compared to a net loss of ¥128,680,180.54 in the previous period, showing an improvement of approximately 23.9%[26] - The total comprehensive loss for the current period was ¥97,789,957.12, compared to a loss of ¥128,680,180.54 in the previous period, indicating a reduction of approximately 23.9%[26] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,412,765,287.53, an increase of 1.67% from the end of the previous year[5] - The company's equity attributable to shareholders decreased by 11.09% to ¥720,204,117.77 compared to the end of the previous year[5] - The total liabilities increased to ¥657,283,343.56 from ¥580,236,647.94, marking a rise of approximately 13.3%[22] - The company's total non-current assets increased from CNY 556,315,198.38 to CNY 670,628,319.78, representing a growth of about 20.5%[21] Cash Flow - Cash flow from operating activities showed a net outflow of -¥31,266,571.31, a significant increase of 76.19% in outflow compared to the previous year[5] - The net cash flow from operating activities improved to -¥31,266,571.31, a 76.19% reduction in losses compared to the previous period, driven by increased cash receipts from sales[9] - The net cash flow from operating activities was ¥423,581,404.26, compared to ¥310,972,034.04 in the previous period, reflecting an increase of about 36.1%[27] - The net cash flow from financing activities was $22.95 million, compared to $37.77 million in the previous period, showing a decline in cash generated from financing[28] Investments and Expenses - The company reported a significant increase in financial expenses, totaling ¥2,418,111.69, which is a 372.53% rise due to higher interest expenses[9] - Investment income decreased by 78.08% to ¥925,141.75, mainly due to reduced returns from financial products[9] - Cash outflows for investment activities were $443.98 million, down from $977.72 million, indicating a reduction in capital expenditures[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,346, with the largest shareholder holding 27.01% of the shares[10] - The company completed the repurchase and cancellation of 1.24 million restricted stocks, with a total expenditure of CNY 23,240,080, reducing the total share capital from 104,693,400 shares to 103,453,400 shares[16] Goodwill and Deferred Tax - The goodwill increased by 73.01% to ¥89,282,534.55, attributed to the acquisition of new companies during the period[8] - The company experienced a 380.33% increase in deferred tax liabilities, reaching ¥19,696,969.11, mainly due to the impact of newly acquired companies[8] - The company’s goodwill rose from CNY 51,603,994.78 to CNY 89,282,534.55, an increase of approximately 73%[21] Operating Costs - Operating costs amounted to ¥318,794,825.33, reflecting an 86.61% increase, attributed to higher costs associated with increased revenue[9] - Total operating costs amounted to ¥497,244,925.84, up from ¥342,051,160.29, indicating an increase of about 45.5%[25] Other Income - The company received other income of ¥3,152,097.94, a 70.82% increase, attributed to higher government subsidies compared to the previous year[9] - The company received $115.40 thousand in tax refunds, compared to $29.76 thousand previously, indicating improved tax recovery[28]

Financial Performance - The company's operating revenue for the third quarter was ¥560,572,237.04, representing a year-on-year increase of 1.55%[5] - The total profit for the quarter was ¥5,572,845.45, with a year-to-date profit of ¥46,729,782.50, reflecting a decrease of 75.05% compared to the previous year[5] - The net profit attributable to shareholders for the quarter was ¥7,141,824.59, showing a significant increase of 300.79% year-on-year, while the year-to-date figure decreased by 72.88% to ¥41,731,591.44[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses for the quarter was ¥4,487,229.62, up 125.39% year-on-year, with a year-to-date decrease of 67.55%[5] - The basic earnings per share for the quarter was ¥0.0041, an increase of 310.00% year-on-year, while the year-to-date figure decreased by 72.86% to ¥0.0241[6] - The net profit for the first three quarters of 2025 is CNY 33,145,133.05, a decrease of 78.9% compared to CNY 156,966,367.37 in the same period of 2024[32] - The total revenue from operating activities for the first three quarters of 2025 is CNY 3,363,574,692.13, down 22.1% from CNY 4,318,367,165.52 in the previous year[36] - The total operating profit for the first three quarters of 2025 is CNY 47,503,634.25, down 74.7% from CNY 187,986,517.69 in the same period of 2024[32] Assets and Liabilities - The total assets at the end of the reporting period were ¥18,089,807,907.64, a decrease of 3.25% compared to the end of the previous year[6] - The equity attributable to shareholders at the end of the reporting period was ¥7,030,255,958.69, reflecting an increase of 0.78% compared to the end of the previous year[6] - As of September 30, 2025, the company's total current assets amounted to RMB 2,045,921,358.69, a slight decrease from RMB 2,053,893,062.15 on December 31, 2024[25] - The company's total liabilities as of September 30, 2025, were RMB 10,532,092,471.52, down from RMB 11,186,063,838.18 at the end of 2024[27] - The company’s non-current assets totaled RMB 16,043,886,548.95 as of September 30, 2025, down from RMB 16,643,982,680.51 at the end of 2024[26] - The company’s total equity as of September 30, 2025, was RMB 7,557,715,436.12, slightly up from RMB 7,511,811,904.48 at the end of 2024[27] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥245,029,853.16, down 69.23% compared to the previous year[5] - The net cash flow from operating activities for the first three quarters of 2025 is CNY 245,029,853.16, a decline of 69.1% compared to CNY 796,373,503.57 in the same period of 2024[37] - The company’s cash and cash equivalents as of September 30, 2025, were RMB 207,123,150.61, compared to RMB 246,530,768.21 at the end of 2024, reflecting a decrease of approximately 16%[25] - The cash and cash equivalents at the end of the third quarter of 2025 amount to CNY 176,542,672.84, compared to CNY 162,537,862.23 at the end of the same period in 2024[37] Shareholder Information - The total number of common shareholders at the end of the reporting period is 30,264[13] - Shenzhen Maoye Commercial Co., Ltd. holds 1,401,135,188 shares, accounting for 80.90% of the total shares[14] Financing Activities - The company plans to apply for a loan of RMB 48 million from Industrial and Commercial Bank of China, with a term of 12 months, secured by a property of 7,733 square meters[15] - The company intends to apply for a comprehensive credit limit of RMB 120 million from Shanghai Pudong Development Bank, with a term of 24 months, secured by commercial properties totaling 18,766.37 square meters[16] - The company plans to borrow up to RMB 140 million from its controlling shareholder, with a term of 3 years, without any collateral or guarantees[17] - The company intends to apply for a comprehensive credit limit of RMB 300 million from China Minsheng Bank, secured by a property of 38,002.71 square meters[18] - The company plans to apply for a comprehensive credit limit of RMB 200 million from Guangfa Bank, with the loan secured by a commercial property of 38,470.86 square meters[19] - The company plans to apply for a working capital loan of RMB 100 million from Ordos Bank, with a term not exceeding one year, secured by commercial properties totaling 40,064.84 square meters[20] Management Strategy - The company emphasized its strategy of optimizing management and improving quality and efficiency, which contributed to the revenue growth despite the overall decline in profit[10] Audit and Compliance - The company has approved the renewal of the accounting firm for the 2025 financial year, continuing with Xinyong Zhonghe for financial and internal control audits[21] Other Financial Metrics - The company reported a total comprehensive income of CNY 30,476,164.18 for the first three quarters of 2025, significantly lower than CNY 175,387,549.61 in the previous year[32] - The basic and diluted earnings per share for the first three quarters of 2025 are CNY 0.0241, down 72.8% from CNY 0.0888 in the same period of 2024[32] - The company incurred financial expenses of CNY 212,037,506.21 in the first three quarters of 2025, a decrease of 16.3% from CNY 253,235,411.05 in the previous year[32] - The company reported a tax expense of CNY 13,584,649.45 for the first three quarters of 2025, a decrease of 55.3% compared to CNY 30,340,443.23 in the previous year[32]

证券代码：603082 证券简称：北自科技 北自所（北京）科技发展股份有限公司 2025 年第三季度报告 北自所（北京）科技发展股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 注："本报告期"指本季度初至本季度末 3 个月期间，下同。 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | ...

Financial Performance - The company's operating revenue for the third quarter was CNY 1,083.20 million, a slight increase of 0.15% compared to CNY 1,081.62 million in the same period last year[4] - The total profit for the quarter reached CNY 101.99 million, representing a year-on-year increase of 21.44% from CNY 83.99 million[4] - Net profit attributable to shareholders was CNY 81.43 million, up 31.06% from CNY 62.13 million in the previous year[5] - The basic earnings per share for the quarter was CNY 0.20, reflecting a 33.33% increase from CNY 0.15 in the same period last year[5] - Total operating revenue for the first three quarters of 2025 reached CNY 3,018,367,909.49, a slight increase of 0.4% compared to CNY 3,005,233,177.12 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was CNY 116,596,401.89, compared to CNY 86,925,573.60 in 2024, representing a growth of about 34.1%[20] - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY 0.26, an increase from CNY 0.19 in the same period of 2024[21] - The total comprehensive income for the first three quarters of 2025 was CNY 116,518,640.27, compared to CNY 100,389,366.14 in 2024, indicating an increase of approximately 16.1%[21] Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,636.48 million, a decrease of 12.36% compared to the previous year[5] - As of September 30, 2025, Shanghai JianKe Consulting Group Co., Ltd. reported total assets of RMB 5,636,480,195.64, a decrease from RMB 6,431,534,374.75 as of December 31, 2024, reflecting a decline of approximately 12.35%[15] - The company's current assets amounted to RMB 3,376,969,410.57, down from RMB 4,076,859,035.24, indicating a decrease of about 17.19%[15] - Total liabilities decreased to CNY 1,730,991,953.83 in 2025 from CNY 2,036,844,650.53 in 2024, indicating a reduction of approximately 15%[17] - Total equity attributable to shareholders of the parent company decreased to CNY 3,622,961,373.83 in 2025 from CNY 4,104,746,181.34 in 2024, a decline of about 11.7%[17] Cash Flow - The company reported a net cash flow from operating activities of CNY -422.16 million, indicating a decline from CNY -448.36 million in the previous year[5] - Cash inflow from operating activities for the first three quarters of 2025 was approximately $3.27 billion, a decrease of 2.7% compared to $3.37 billion in the same period of 2024[23] - The company reported a total cash outflow of approximately -$1.49 billion for the first three quarters of 2025, compared to -$1.32 billion in the same period of 2024[24] - Cash inflow from financing activities was approximately $45.15 million, marginally up from $45.10 million in the previous year[24] - Net cash outflow from financing activities was approximately -$185.43 million, an improvement from -$308.02 million in the same period of 2024[24] Operational Highlights - The company has increased its business expansion efforts, which contributed to the growth in operating revenue and net profit[10] - The company has made adjustments to the previous year's data due to the acquisition of Shanghai Investment Consulting Group Co., Ltd. in January 2025[6] - The weighted average return on equity for the quarter was 2.28%, an increase of 0.34 percentage points from 1.94% in the previous year[5] - Research and development expenses for the first three quarters of 2025 were CNY 203,181,829.49, up from CNY 183,203,746.94 in 2024, marking an increase of approximately 10.9%[19] - Other income increased significantly to CNY 69,273,850.32 in 2025 from CNY 33,855,081.91 in 2024, reflecting a growth of about 104.5%[19] Shareholder Information - The company reported a total of 6,124,910 shares held in the repurchase special securities account, accounting for 1.49% of the total share capital[14] - The company has not reported any significant changes in the participation of major shareholders in margin trading and securities lending activities[14] - The company has not disclosed any new strategies or future outlook during the earnings call[14] - There were no significant updates regarding new product developments or market expansions mentioned in the conference call[14] Impairment and Losses - The company reported a financial asset impairment loss of CNY -31,739,013.22 in 2025, an improvement from CNY -46,891,473.11 in 2024[20] Accounting Standards - The company has not adopted new accounting standards for the year 2025[26]

Financial Performance - The company's revenue for the third quarter reached ¥1,024,945,346.74, representing a 47.05% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥38,141,036.13, up 23.65% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥37,388,325.62, an increase of 31.09%[5] - Total operating revenue for the current period reached ¥2,639,520,974.02, a significant increase from ¥1,735,993,627.41 in the previous period, representing a growth of approximately 52.0%[22] - Net profit for the current period was ¥93,855,829.37, slightly down from ¥95,551,657.74, reflecting a decrease of approximately 1.8%[23] - The total comprehensive income for the period attributable to the parent company was ¥93,972,237.82, compared to ¥95,551,654.68 in the previous period, reflecting a decrease[24] - Basic and diluted earnings per share were both ¥0.6906, down from ¥0.7029 in the previous period[24] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥4,920,211,152.21, reflecting a 15.72% increase from the end of the previous year[5] - Total assets reached ¥4,920,211,152.21, up from ¥4,251,930,367.78, indicating a growth of approximately 15.7%[21] - Total liabilities increased to ¥2,634,789,854.36 from ¥1,972,495,852.23, reflecting a rise of about 33.5%[21] Cash Flow - The company's cash flow from operating activities showed a significant decline, with a net outflow of ¥676,704,643.66, a decrease of 3,425.43% compared to the previous period[12] - The net cash flow from operating activities was -¥676,704,643.66, a significant decline from -¥19,194,939.01 in the previous period[27] - Cash inflow from operating activities totaled ¥2,047,636,949.50, up from ¥1,504,392,979.04 year-over-year[27] - The cash outflow from operating activities increased to ¥2,724,341,593.16, compared to ¥1,523,587,918.05 in the previous period[27] - The net cash flow from investing activities was ¥134,886,294.15, an increase from ¥118,526,114.64 in the previous period[27] - Cash inflow from financing activities was ¥684,880,976.67, compared to ¥134,970,544.69 in the previous period[27] - The net cash flow from financing activities improved to ¥446,902,243.39 from -¥3,433,013.34 in the previous period[27] - The ending balance of cash and cash equivalents was ¥480,231,430.01, compared to ¥458,063,624.90 in the previous period[28] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 9,434[14] - The top two shareholders, Bu Xiaohua and Sun Qunxia, each hold 21.53% of the shares, totaling 29,400,000 shares[14] - Yang Yuwei holds 18.45% of the shares, amounting to 25,200,000 shares, with 18,900,000 shares under lock-up[15] - The total number of restricted shares at the beginning of the period was 86,310,280, with no changes during the period[17] - The company has a total of 86,310,280 restricted shares, with the majority set to be released in December 2026[17] - No new shares were added or released during the reporting period for major shareholders[17] - There are no significant changes in the shareholder structure or any mergers and acquisitions reported[18] Operational Costs and Investments - The gross profit margin for the period was impacted by a 54.37% increase in operating costs, totaling ¥2,378,516,103.09, driven by revenue growth[11] - Total operating costs amounted to ¥2,527,658,852.51, up from ¥1,635,631,366.23, indicating a rise of about 54.5%[22] - Research and development expenses increased by 66.33% to ¥88,351,861.09, indicating a focus on innovation and product development[11] - Research and development expenses for the current period were ¥88,351,861.09, compared to ¥53,119,551.89 in the previous period, indicating a rise of about 66.3%[23] - The company reported a 160.35% increase in receivables financing, totaling ¥367,041,728.70, due to increased sales collections[9] - The long-term equity investments rose by 55.75% to ¥41,468,763.67, reflecting increased investments in joint ventures[9] - Long-term equity investments grew to ¥41,468,763.67 from ¥26,625,825.58, showing an increase of approximately 55.7%[20] - Accounts receivable increased to ¥1,727,543,477.03 from ¥1,472,568,365.38, marking a growth of about 17.3%[20] - Inventory levels rose to ¥531,232,524.47, compared to ¥341,968,627.88, which is an increase of approximately 55.5%[20] Borrowings - The company experienced a 505.09% increase in short-term borrowings, amounting to ¥497,184,008.24, primarily due to increased bank loans[9] - Short-term borrowings surged to ¥497,184,008.24 from ¥82,167,484.77, representing a dramatic increase of about 505.5%[21]

罗欣药业集团股份有限公司 2025 年第三季度报告 证券代码：002793 证券简称：罗欣药业 公告编号：2025-098 罗欣药业集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 646,173,009.72 | 3.94% | 1,723,415,167.25 | -8.37% | | 归属于上市公司股东 | 5,231,766.19 | 102.96% | 22,926,815.63 | ...

Revenue and Profitability - The company's revenue for the third quarter reached ¥131,635,839.32, representing a year-on-year increase of 52.47%[5] - Net profit attributable to shareholders decreased by 17.32% to ¥9,423,037.59, while the year-to-date net profit dropped by 56.46% to ¥16,523,162.52[5] - The basic earnings per share for the quarter was ¥0.1290, down 17.01% compared to the same period last year[5] - Total operating revenue for the current period reached ¥287,496,061.08, an increase of 3.25% compared to ¥277,593,857.27 in the previous period[18] - Net profit for the current period was ¥15,926,920.67, a decrease of 57.53% from ¥37,536,786.94 in the previous period[19] - Earnings per share (EPS) for the current period was ¥0.2263, down from ¥0.5176 in the previous period[19] - The total comprehensive income for the current period was ¥15,926,920.67, down from ¥37,536,786.94 in the previous period[19] Assets and Liabilities - Total assets increased by 9.03% to ¥1,843,763,983.45 compared to the end of the previous year[5] - Total assets increased to ¥1,843,763,983.45, compared to ¥1,691,031,233.85 in the previous period, reflecting a growth of 9.05%[17] - Total liabilities rose to ¥215,428,276.29, up from ¥71,453,774.84 in the previous period, indicating a significant increase[17] - Total equity attributable to shareholders of the parent company was ¥1,618,324,573.50, slightly up from ¥1,609,970,083.50 in the previous period[16] Cash Flow - Cash flow from operating activities showed a significant decline, with a net outflow of ¥66,333,448.47, a decrease of 179.10% year-to-date[5] - Operating cash flow net amount decreased to -$66.33 million from $83.86 million in the previous period, indicating a significant decline in operational performance[21] - Cash received from sales of goods and services decreased by 39.17% to ¥119,986,710.39, primarily due to an increase in accounts receivable[9] - Cash received from sales of goods and services was $119.99 million, down from $197.25 million, indicating a decline of about 39.2%[21] - Cash inflow from investment activities totaled $1.99 billion, slightly down from $2.05 billion, while cash outflow decreased to $1.77 billion from $2.63 billion, resulting in a net cash flow from investment activities of $229.85 million[21] - Financing activities generated a cash inflow of $1 million, down from $10 million, with cash outflow increasing to $100.19 million from $29.99 million, leading to a net cash flow from financing activities of -$99.19 million[22] - The total cash and cash equivalents at the end of the period amounted to $134.26 million, compared to $193.00 million in the previous period, reflecting a decrease of approximately 30.4%[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,548[11] - The largest shareholder, Gu Ting, holds 34.11% of shares, totaling 25,012,500 shares[11] - The number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, with Gu Ting and Gu Ren together holding over 51%[11] - The company has a total of 0.52% of its shares repurchased through a dedicated securities account[12] Expenses and Investments - The company reported a 31.23% increase in management expenses, totaling ¥18,498,261.24, mainly due to higher personnel costs[9] - Research and development expenses for the current period were ¥20,299,985.93, an increase of 21.06% from ¥16,640,773.03 in the previous period[18] - The company reported an investment income of ¥18,662,564.16, compared to ¥14,549,518.96 in the previous period, marking a growth of 28.93%[18] - The company has invested in construction projects, with construction in progress valued at ¥85,488,130.18, up from ¥10,145,803.57[15] Accounts Receivable and Cash Management - Accounts receivable rose by 142.10% to ¥121,162,692.69, attributed to increased sales in the third quarter[8] - Accounts receivable rose to ¥121,162,692.69 from ¥50,047,439.93, indicating an increase of about 142%[15] - Cash received from tax refunds increased significantly to $12.43 million from $2.24 million, showing a growth of approximately 454.5%[21] - Cash paid for purchasing goods and services rose to $120.51 million from $50.97 million, marking an increase of about 136.3%[21] - Cash paid to employees increased to $56.88 million from $48.71 million, reflecting a rise of approximately 16.5%[21] Audit and Reliability - The financial report for the third quarter was not audited, which may affect the reliability of the reported figures[23]

深圳市特力(集团)股份有限公司 2025 年第三季度报告 证券代码：000025、200025 证券简称：特力Ａ、特力 B 公告编号：2025-033 深圳市特力(集团)股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 深圳市特力(集团)股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 （二） 非经常性损益项目和金额 适用 □不适用 单位：元 | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益（包括已计提资产减值准备的冲销部分 ...

Financial Performance - The company's operating revenue for Q3 2025 reached ¥10,781,027,302.94, representing a year-on-year increase of 14.98%[4] - Net profit attributable to shareholders was ¥88,180,787.96, a significant increase of 59.96% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥111,588,501.72, up 168.32% year-on-year[4] - Basic and diluted earnings per share for Q3 2025 were both ¥0.17, marking a 54.55% increase compared to the previous year[4] - Total operating revenue increased to ¥33,083,996,190.59, up from ¥30,730,673,434.38, representing a growth of approximately 7.7% year-over-year[19] - Net profit for the period reached ¥503,507,717.83, a significant increase from ¥287,571,688.27, marking a growth of approximately 75.1% year-over-year[20] - Basic and diluted earnings per share increased to ¥0.43 from ¥0.31 year-over-year[21] - Total comprehensive income amounted to ¥518,295,660.08, an increase from ¥229,157,011.89 in the previous period[21] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was ¥1,525,589,857.00, reflecting a substantial increase of 709.25%[4] - The company's cash and cash equivalents decreased from 3,548,115,234.85 RMB to 3,012,689,497.83 RMB[15] - Cash inflow from operating activities totaled ¥37,534,752,700.16, compared to ¥33,166,005,707.71 in the previous period[22] - Cash outflow for investing activities was ¥2,454,529,548.80, up from ¥1,212,408,346.75 year-over-year, resulting in a net cash flow from investing activities of -¥1,969,881,441.74[23] - Cash flow from financing activities generated a net increase of ¥145,263,380.91, compared to a net decrease of -¥663,643,146.07 in the previous year[23] - The ending balance of cash and cash equivalents decreased to ¥1,777,261,978.43 from ¥2,474,145,679.42 year-over-year[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,238[10] - The largest shareholder, Zhejiang Nong Holding Group Co., Ltd., holds 19.51% of shares, totaling 101,714,094 shares[10] - The company has repurchased 11,888,937 shares, accounting for 2.28% of the total share capital, with a total transaction amount of 100,449,350.50 RMB[11] - Zhejiang Xinghe Group plans to increase its shareholding by 0.50% to 1.00% of the total share capital, with a maximum purchase price of 9.80 RMB per share[12] Operational Highlights - The company focused on developing its agricultural comprehensive service business, which saw continuous growth in sales volume and revenue[8] - The automotive trading service faced challenges in a competitive market but maintained overall industry-leading operational quality[8] - The company improved its cash flow by capitalizing on seasonal demand and increasing inventory turnover, leading to significant cash recovery from sales[8] Liabilities and Equity - Current liabilities totaled ¥12,451,018,599.81, compared to ¥10,261,250,117.07, reflecting an increase of approximately 21.4% year-over-year[17] - Long-term liabilities increased to ¥858,935,858.91 from ¥763,497,474.37, representing a growth of about 12.5%[17] - The company's equity attributable to shareholders rose to ¥4,796,011,579.58, compared to ¥4,744,160,369.75, an increase of approximately 1.1%[17] Non-Recurring Items - Non-recurring gains and losses for the reporting period totaled -¥23,407,713.76, indicating a decrease compared to the previous year[6] Investment Activities - Trading financial assets increased significantly from 864,773,240.00 RMB to 2,791,676,095.65 RMB[15] - Revenue from sales of goods and services reached ¥37,223,020,685.95, up from ¥32,833,352,820.36 in the previous period[22] - Total cash inflow from investment activities was ¥484,648,107.06, down from ¥756,361,089.03 year-over-year[23] Other Information - The company is in the process of transferring 100% equity of its wholly-owned subsidiary, Huadong Pharmaceutical, for a price of 36,910,000 RMB[13] - The company is currently undergoing an antitrust review for the equity transfer, which introduces uncertainty into the transaction[13] - Research and development expenses were reported at ¥12,317,416.70, slightly down from ¥13,344,271.83, indicating a decrease of about 7.7% year-over-year[20] - Investment income increased significantly to ¥95,294,814.19 from ¥27,612,165.92, marking a growth of approximately 245.5% year-over-year[20] - Other comprehensive income after tax amounted to ¥14,787,942.25, compared to a loss of ¥58,414,676.38 in the previous period[20] - The company did not undergo an audit for the third quarter financial report[26]